Cure8 research brief
The study links NEAT1, a long noncoding RNA, to neutrophil-driven mucosal inflammation in ulcerative colitis and suggests NEAT1 affects neutrophil activity via glycolysis. That points to a new molecular pathway that could be explored for treatments or biomarkers.
Researchers in IBD immunology and metabolism; clinician-scientists working on UC; patients and advocates tracking new mechanistic research
The paper reports higher NEAT1 expression in inflamed tissue and neutrophils from people with ulcerative colitis and shows, in a mouse DSS colitis model and in vitro neutrophil assays, that loss of NEAT1 lowers several neutrophil inflammatory functions (cytokines, chemokines, ROS, NETs).
The authors present data that NEAT1 influences neutrophil activity at least in part through effects on glycolytic metabolism. These findings are preclinical and mechanistic rather than clinical; they provide a biological rationale for further research on NEAT1 as a possible therapeutic or biomarker in UC.
Findings are from preclinical experiments (mouse DSS colitis model and in vitro neutrophil assays) and an analysis of patient tissue; this is mechanistic research rather than evidence of a clinical treatment. The structured content is based on the article abstract.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study links a cellular signaling pathway that increases serotonin release from gut enterochromaffin cells to inflammation in a mouse model of ulcerative colitis. If confirmed, blocking TRPV4 could become a research...
The study suggests a possible link between psoriasis, leaky gut, and Crohn’s disease—topics that could help explain why some people with psoriasis report more gut problems. People with psoriasis or IBD may find the...
Intestinal fibrosis is a serious complication of long-standing ulcerative colitis. Identifying NET-related biomarkers (IL1RN, MUC1, SERPINA1) could help researchers develop better diagnostic tools or treatments targeting...
